The effectiveness of a televisit service for people with type 1 diabetes: An observational, retrospective, single center, one year follow-up study

Basilio Pintaudi; Ilaria Gironi; Olga Disoteo; Elena Meneghini; Elen Mion; Oscar Massimiliano Epis; Federico Bertuzzi

doi:10.1016/j.diabres.2022.109960

The effectiveness of a televisit service for people with type 1 diabetes: An observational, retrospective, single center, one year follow-up study

Diabetes Res Clin Pract. 2022 Jul:189:109960. doi: 10.1016/j.diabres.2022.109960. Epub 2022 Jun 13.

Authors

Basilio Pintaudi¹, Ilaria Gironi², Olga Disoteo², Elena Meneghini², Elen Mion², Oscar Massimiliano Epis², Federico Bertuzzi²

Affiliations

¹ Diabetes Unit, Niguarda Ca Granda Hospital, Milan, Italy. Electronic address: basilio.pintaudi@ospedaleniguarda.it.
² Diabetes Unit, Niguarda Ca Granda Hospital, Milan, Italy.

PMID: 35709912
DOI: 10.1016/j.diabres.2022.109960

Abstract

The use of a televisit service complying with efficiency and safety regulatory parameters was effective in significantly improving HbA1c levels of people with T1D after a one-year follow-up period. No acute diabetes-related complications occurred. Patients were highly satisfied with the service. Televisit is a valid option for diabetes management.

Keywords: COVID-19; Telemedicine; Type 1 diabetes.

Publication types

Observational Study

MeSH terms

Diabetes Complications*
Diabetes Mellitus, Type 1* / therapy
Follow-Up Studies
Humans
Retrospective Studies
Telemedicine*